148 related articles for article (PubMed ID: 8708392)
1. Detection of point mutations in K-ras gene at codon 12 in bile from percutaneous transhepatic choledochal drainage tubes for diagnosis of biliary strictures.
Ajiki T; Onoyama H; Yamamoto M; Fujimori T; Maeda S; Saitoh Y
Int J Pancreatol; 1995 Dec; 18(3):215-20. PubMed ID: 8708392
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of K-ras gene mutation at codon 12 in bile for diagnosing biliary strictures.
Ito R; Tamura K; Ashida H; Nishiwaki M; Nishioka A; Yamamoto Y; Furuyama JI; Utsunomiya J
Int J Oncol; 1998 May; 12(5):1019-23. PubMed ID: 9538122
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.
Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N
J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567
[TBL] [Abstract][Full Text] [Related]
4. Rapid detection of K-ras mutations in bile by peptide nucleic acid-mediated PCR clamping and melting curve analysis: comparison with restriction fragment length polymorphism analysis.
Chen CY; Shiesh SC; Wu SJ
Clin Chem; 2004 Mar; 50(3):481-9. PubMed ID: 14718395
[TBL] [Abstract][Full Text] [Related]
5. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction.
Matsubara T; Sakurai Y; Sasayama Y; Hori H; Ochiai M; Funabiki T; Matsumoto K; Hirono I
Cancer; 1996 Apr; 77(8 Suppl):1752-7. PubMed ID: 8608574
[TBL] [Abstract][Full Text] [Related]
6. K-ras point mutations in the supernatants of pancreatic juice and bile are reliable for diagnosis of pancreas and biliary tract carcinomas complementary to cytologic examination.
Yamashita K; Kida Y; Shinoda H; Kida M; Okayasu I
Jpn J Cancer Res; 1999 Feb; 90(2):240-8. PubMed ID: 10189896
[TBL] [Abstract][Full Text] [Related]
7. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers.
Itoi T; Takei K; Shinohara Y; Takeda K; Nakamura K; Horibe T; Sanada A; Ohno H; Matsubayashi H; Saito T; Watanabe H
Pathol Int; 1999 Jan; 49(1):30-7. PubMed ID: 10227722
[TBL] [Abstract][Full Text] [Related]
8. Detection of point mutations in the K-ras oncogene at codon 12 in pure pancreatic juice for diagnosis of pancreatic carcinoma.
Kondo H; Sugano K; Fukayama N; Kyogoku A; Nose H; Shimada K; Ohkura H; Ohtsu A; Yoshida S; Shimosato Y
Cancer; 1994 Mar; 73(6):1589-94. PubMed ID: 8156485
[TBL] [Abstract][Full Text] [Related]
9. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
[TBL] [Abstract][Full Text] [Related]
10. Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.
Stork P; Loda M; Bosari S; Wiley B; Poppenhusen K; Wolfe H
Oncogene; 1991 May; 6(5):857-62. PubMed ID: 1646989
[TBL] [Abstract][Full Text] [Related]
11. Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing.
Tada M; Yokosuka O; Omata M; Ohto M; Isono K
Cancer; 1990 Sep; 66(5):930-5. PubMed ID: 2167148
[TBL] [Abstract][Full Text] [Related]
12. Detection of Ki-ras gene point mutations in bile specimens for the differential diagnosis of malignant and benign biliary strictures.
Saurin JC; Joly-Pharaboz MO; Pernas P; Henry L; Ponchon T; Madjar JJ
Gut; 2000 Sep; 47(3):357-61. PubMed ID: 10940271
[TBL] [Abstract][Full Text] [Related]
13. Detection of mutated c-Ki-ras in the bile of patients with pancreatic cancer.
Abbruzzese JL; Evans DB; Raijman I; Larry L; King T; Leach SD; Frazier ML
Anticancer Res; 1997; 17(2A):795-801. PubMed ID: 9137410
[TBL] [Abstract][Full Text] [Related]
14. [Sensitive detection of K-ras oncogene codon 12 mutations by nested PCR using mismatched primers and selective digestion of non-mutated PCR fragments with restriction enzyme].
Fukayama N; Sugano K; Kyogoku A; Nose H; Kondou H; Ohkura H
Rinsho Byori; 1993 Sep; 41(9):1017-23. PubMed ID: 8254964
[TBL] [Abstract][Full Text] [Related]
15. ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications.
Zambon C; Navaglia F; Basso D; Gallo N; Greco E; Piva MG; Fogar P; Pasquali C; Pedrazzoli S; Plebani M
Clin Chim Acta; 2000 Dec; 302(1-2):35-48. PubMed ID: 11074062
[TBL] [Abstract][Full Text] [Related]
16. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis.
Imai M; Hoshi T; Ogawa K
Cancer; 1994 Jun; 73(11):2727-33. PubMed ID: 8194013
[TBL] [Abstract][Full Text] [Related]
17. Polymerase chain reaction-based K-ras mutation detection of pancreatic adenocarcinoma in routine cytology smears.
Apple SK; Hecht JR; Novak JM; Nieberg RK; Rosenthal DL; Grody WW
Am J Clin Pathol; 1996 Mar; 105(3):321-6. PubMed ID: 8602613
[TBL] [Abstract][Full Text] [Related]
18. Analysis of K-ras oncogene mutation directly applied to atypical cell clusters on cytologic smear slides of bile and pancreatic juice.
Fukushima N; Suzuki M; Fukayama M
Pathol Int; 1998 Jan; 48(1):33-40. PubMed ID: 9589462
[TBL] [Abstract][Full Text] [Related]
19. [Mutation of the K-ras oncogene in pancreatic carcinoma, and application of its detection in pancreatic juice to diagnose pancreatic carcinoma].
Sawabu N; Watanabe H; Yamaguchi Y; Okai T
Nihon Rinsho; 1995 Feb; 53(2):511-7. PubMed ID: 7699881
[TBL] [Abstract][Full Text] [Related]
20. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
